PTC Therapeutics (PTCT) Stock: Buy, Sell, or Hold?
$63.36
-1.55 (-2.39%)
âŧ
5d:
-3.52%
30d:
+6.18%
90d:
-11.63%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect PTCT Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (78%)
Quality Score
44/100
Position
FAIR
30-Day Fair Range
$60.73 â $65.36
Position: FAIR
Forward P/E & Valuation
19.9x
CHEAP
vs 26.7x historical avg
Wall Street Target
$100.47
+58.6% upside
Options IV & Volume
5th pct IV
HIGH volume confirmation
Support / Resistance
$59.16 / $70.11
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: PTCT is fairly priced but lacks strong directional signals. At -9.4% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When PTCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$155.30
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$96.43
34.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PTCT is currently trading at $63.36, which is considered fair relative to its 30-day fair value range of $60.73 to $65.36. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.9) compared to its historical average (26.7). Remarkably, the market is currently pricing in an annual earnings decline of 9.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PTCT is in a strong downtrend. Immediate support is located at $59.16, while resistance sits at $70.11.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $100.47 (+58.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PTCT is in a strong downtrend. Immediate support is located at $59.16, while resistance sits at $70.11.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $100.47 (+58.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$60.73 -
$65.36
Company Quality Score
44/100
(HOLD)
Options IV Signal
5th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
77.7%
Trading Range & Key Levels
30-Day Trading Range
$60.73 -
$65.36
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$4.62
(7.3%)
Support Level
$59.16
Resistance Level
$70.11
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding PTCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 5th percentile)
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 58.6% below Wall St target ($100.47)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.86
Wall Street Target
$100.47
(+58.6%)
Revenue Growth (YoY)
69.6%
Profit Margin
-9.2%
Valuation Discount vs History
-9.4% cheaper
PE vs Historical
19.9 vs 26.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.4%
(market-implied from PE analysis)
1-Year Target
$57.40
(-9%)
2-Year Target
$52.01
(-18%)
3-Year Target
$47.12
(-26%)
3-Yr Target (if PE normalizes)
(PE: 20â27)
$63.34
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 241.2%)
$213.84
(+238%)
Base:
(SPY PE: 19.9, Growth: 241.2%)
$213.82
(+238%)
Bear:
(PE: 16.9, Growth: 241.2%)
$181.75
(+187%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.9 to 26.7
Stabilization Target:
$85.17
(+34.4%)
PE Expansion Potential:
+34.4%
Share PTCT Analysis
Share this live PTCT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PTCT)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits regarding $PTCT's stock buyback, with some traders questioning the move for a single-product company.
Key Retail Themes:
Stock buyback
Company product offerings
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:25 AM ET
Data refreshes hourly during market hours. Next update: 5:25 AM
Data refreshes hourly during market hours. Next update: 5:25 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Advanced PTCT Option Strategies
Professional options setups generated by AI based on today's PTCT price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PTCT Research Pages
